Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		14 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022
OPERATING ACTIVITIES
Net (loss) income	$ (42,763,000)	$ 51,464,000	$ (43,839,000)	$ 52,717,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Gain on sales				(49,904,000)
Impairment charges (reversal)			16,829,000	(1,849,000)
Straight-line rents and expenses, net			(4,000)	(305,000)
Provision for doubtful accounts			840,000	502,000
Depreciation and amortization			15,066,000	21,468,000
Amortization of intangible lease liabilities, net			(506,000)	(539,000)
Expense relating to share-based compensation, net			823,000	1,926,000
Amortization of deferred financing costs			440,000	748,000
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:
Rents and other receivables			(1,006,000)	(591,000)
Prepaid expenses and other			3,659,000	1,276,000
Accounts payable and accrued liabilities			23,780,000	(645,000)
Net cash provided by operating activities			16,082,000	24,804,000
INVESTING ACTIVITIES
Expenditures for real estate improvements			(16,932,000)	(13,762,000)
Net proceeds from sales of real estate			31,866,000	104,497,000
Contributions to unconsolidated joint venture			(155,000)	(2,481,000)	$ (4,800,000)
Net cash provided by investing activities			14,779,000	88,254,000
FINANCING ACTIVITIES
Repayments under revolving credit facility			(29,000,000)	(183,000,000)
Advances under revolving credit facility			4,000,000	20,000,000
Repayment of term note				(50,000,000)
Termination payment related to interest rate swap				(503,000)
Mortgage proceeds				114,000,000
Mortgage repayments			(571,000)	(548,000)
Payments of debt financing costs			(6,000)	(1,620,000)
Noncontrolling interests:
Distributions to limited partners			(5,000)	(10,000)
Acquisition of joint venture minority interest share			(1,000,000)
Redemption of OP units				(8,000)
Common stock sales less issuance expenses, net				2,000
Preferred stock dividends			(5,376,000)	(5,376,000)
Distributions to common shareholders			(900,000)	(1,799,000)
Net cash used in financing activities			(32,858,000)	(108,862,000)
Net (decrease) increase in cash, cash equivalents and restricted cash			(1,997,000)	4,196,000
Cash, cash equivalents and restricted cash at beginning of period			3,269,000	1,637,000
Cash, cash equivalents and restricted cash at end of period	1,272,000	5,833,000	1,272,000	5,833,000	1,272,000
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	1,042,000	5,603,000	1,042,000	5,603,000	1,042,000
Restricted cash	230,000	230,000	230,000	230,000	230,000
Cash, cash equivalents and restricted cash at end of period	$ 1,272,000	$ 5,833,000	$ 1,272,000	$ 5,833,000	$ 1,272,000